Jefferies Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

November 19, 2025 4:24 AM EST Send to a Friend
Jefferies analyst Eun Yang reiterated a Buy rating and $575.00 price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login